04/30/2024 3:46 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/30/2024 3:35 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/29/2024 4:06 PM | Vaxxinity (Filer)
| Form 10-K/A | |
04/29/2024 3:46 PM | Vaxxinity (Filer)
| Form PRE 14C | |
03/27/2024 3:18 PM | Vaxxinity (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 3:15 PM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2024 3:04 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
12/01/2023 9:30 AM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 4:03 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 4:13 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 4:10 PM | Prime Movers Growth GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023 3:20 PM | Prime Movers Growth GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023 3:21 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 6:53 AM | Vaxxinity (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023 3:31 PM | Paula Molina Rene (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 8:42 PM | Powchik Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 8:40 PM | Ray Sumita (Reporting) Vaxxinity (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/04/2023 3:33 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/28/2023 3:15 PM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 3:12 PM | Prime Movers Growth GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023 3:16 PM | Prime Movers Lab GP I LLC (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:10 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:11 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:14 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:18 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023 4:19 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:34 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:24 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:26 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:31 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023 3:18 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:32 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:00 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:01 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:02 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 4:02 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 4:12 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 4:20 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 3:52 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 3:42 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 5:05 PM | Prime Movers Lab Fund I LP (Reporting) Sloss Dakin (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Dems have chosen Biden replacement? (Ad) On November 16, 2023…
Joe Biden accidentally revealed the name of the candidate…
Who will replace him in the 2024 presidential election. See who it is HERE. |
09/08/2023 4:33 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 4:14 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 4:23 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023 3:50 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:38 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:42 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:26 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:32 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 3:20 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:13 PM | COVAXX PML SPV 2 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:14 PM | Covaxx PML SPV 3 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:15 PM | Covaxx PML SPV 1 LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:16 PM | Prime Movers Growth Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023 3:18 PM | Prime Movers Lab Fund I LP (Reporting) Vaxxinity (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2023 11:15 PM | Vaxxinity (Filer)
| Form EFFECT | |
08/09/2023 6:30 AM | Vaxxinity (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023 6:31 AM | Vaxxinity (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/26/2023 5:31 PM | Powchik Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:32 PM | Diamandis Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:34 PM | TOLEDANO GABRIELLE B (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:35 PM | Eade Katherine A. (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:37 PM | Ogilvie Landon E (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:37 PM | Smith James Alan (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 5:39 PM | HORNIG GEORGE R (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 3:30 PM | Vaxxinity (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2023 6:00 AM | Vaxxinity (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023 4:26 PM | Vaxxinity (Filer)
| Form S-8 POS | |
05/02/2023 9:46 AM | Diamandis Peter (Reporting) Vaxxinity (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |